USMLE Step 2 Clinical Knowledge (CK) Practice Exam

HCV (Hepatitis C virus) treatment significantly improves long-term patient outcomes, particularly by reducing the risk of liver failure. Effective antiviral therapies, such as direct-acting antivirals (DAAs), can lead to complete virological cure in many patients, which in turn halts the progression of liver disease. Patients who achieve sustained virological response (SVR) after treatment are shown to have reductions in the rates of liver-related complications, including cirrhosis and liver failure.

Achieving SVR not only improves liver function but also reduces the risk of developing hepatocellular carcinoma (HCC) in patients with advanced liver disease. While the key focus is on the positive impact of treatment on the liver and associated risks, it is important to note that untreated chronic HCV infection is associated with significant morbidity and mortality due to liver-related complications.

Thus, successful HCV treatment plays a crucial role in enhancing long-term health outcomes for patients, namely by minimizing the likelihood of liver failure and eventually leading to better overall prognosis.